Search Results 181-190 of 4315 for B cell lymphomas
... lymphoma. Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a ...
Munoz specializes in treating lymphomas and he is the Director of the ... Cutaneous b-cell lymphoma · Cutaneous t-cell lymphoma · Diffuse large b-cell ...
... cell therapy, among others. In addition, each week Mayo Clinic lymphoma doctors hold a multidisciplinary meeting to discuss treatment options. These ...
Patients with Burkitt leukemia/lymphoma or mature B-cell leukemia are not eligible; Patients with T-lymphoblastic leukemia (T-ALL)/lymphoblastic lymphoma (T ...
B-cell lymphomas are a heterogeneous group of neoplasms that arise from lymphocytes and produce tumors in the lymph nodes, lymphatic organs and extranodal ...
Blood tests can sometimes show whether lymphoma cells are present. Blood tests may be used to test for viruses, including HIV, EBV, hepatitis B virus and ...
Jacksonville, Fla. The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies ...
... B-cell lymphoma (DLBCL) type and its differentiation from the nodal DLBCL; Genetic analysis of Waldenstrom macroglobulinemia and related marginal zone lymphomas ...
In B-cell non-Hodgkin's lymphoma, cells other than tumor cells are commonly seen within tumor tissue. These cells include T lymphocytes that seem to be more ...
Participation eligibility · B-Cell Lymphoma: Histologically documented lymphomas expected to express CD19; · Chronic Lymphocytic Leukemia (CLL): · Diagnosis of CLL ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.